KALA BIO, Inc. — Director's Dealing 2021

Oct 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kala Pharmaceuticals, Inc. (KALA)
CIK: 0001479419
Period of Report: 2021-10-15

Reporting Person: Myers C. Daniel (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-15	Stock Option (right to buy)	$2.21	A	42000	Acquired	2031-10-14	Common Stock (42000)	Direct

Footnotes

F1: This option was granted on October 15, 2021 and vests with respect to 1/3rd of the shares underlying the option on October 15, 2022 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 15, 2024.